Axillary staging during surgery for breast cancer

British Journal of Surgery

Volumn 94, Issue 3, 2007, Pages 304-309

  Axelsson, C K ^a   Mouridsen, H T ^b   During M ^b   Moller S ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DENMARK; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; DENMARK; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 33947245668     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5599     Document Type: Article

References (31)

1. Eden P, Ritz C, Rose C, Ferno M, Peterson C. 'Good Old' clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers. Eur J Cancer 2004; 40: 1837-1841.
2. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 1992; 28A: 1415-1418.
3. Andersen KW, Mouridsen HT. Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 1988; 27: 627-647.
4. Cady B. Total mastectomy and partial axillary dissection. Surg Clin North Am 1973; 53: 313-318.
5. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-377.
6. Veronesi U, Cascinelli N, Bufalino R, Morabito A, Greco M, Galluzzo D et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 1983; 198: 681-684.
7. Kjaergaard J, Blichert-Toft M, Andersen JA, Rank F, Pedersen BV. Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer. Br J Surg 1985; 72: 365-367.
8. Graversen HP, Blichert-Toft M, Andersen JA, Zedeler K. Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla. Eur J Surg Oncol 1988; 14: 407-412.
9. Du Toit RS, Locker AP, Ellis IO, Elston CW, Blamey RW. Evaluation of the prognostic value of triple node biopsy in early breast cancer. Br J Surg 1990; 77: 163-167.
10. Forrest AP, Everington D, McDonald CC, Steele RJ, Chetty U, Stewart HJ. The Edinburgh randomized trial of axillary sampling or clearance after mastectomy. Br J Surg 1995; 82: 1504-1508.
11. Ahlgren J, Holmberg L, Bergh J, Liljegren G. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer. Eur J Surg Oncol 2002; 28: 97-102.
12. Mathiesen O, Carl J, Bonderup O, Panduro J. Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients. Acta Oncol 1990; 29: 721-725.
13. Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992; 69: 2496-2501.
14. Axelsson CK, Rank F, Blichert-Toft M, Mouridsen HT, Jensen MB. Impact of axillary dissection on staging and regional control in breast tumors
15. Iyer RV, Hanlon A, Fowble B, Freedman G, Nicolaou N, Anderson P et al. Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined. Int J Radiat Oncol Biol Phys 2000; 47: 1177-1183.
16. Somner JE, Dixon JM, Thomas JS. Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status. J Clin Pathol 2004; 57: 845-848.
17. Tominaga T, Takashima S, Danno M. Randomized clinical trial comparing level II and level III axillary node dissection in addition to mastectomy for breast cancer. Br J Surg 2004; 91: 38-43.
18. Fisher B, Slack NH. Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet 1970; 131: 79-88.
19. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981; 152: 765-772.
20. Cserni G. How to improve low lymph node recovery rates from axillary clearance specimens of breast cancer. A short-term audit. J Clin Pathol 1998; 51: 846-849.
21. Hultborn A, Hulten L, Roos B, Rosencrantz M, Rosengren BAC, Ahren C. Effectiveness of axillary lymph node dissection in modified radical mastectomy with preservation of pectoral muscles. Ann Surg 1974; 179: 269-272.
22. European Society of Mastology. The requirements of a specialist breast unit. Eur J Cancer 2000; 36: 2288-2293.
23. Birido N, Geraghty JG. Quality control in breast cancer surgery. Eur J Surg Oncol 2005; 31: 577-586.
24. Rutgers EJ. Guidelines to assure quality in breast cancer surgery. Eur J Surg Oncol 2005; 31: 568-576.
25. Bevilacqua J, Cody H III, MacDonald KA, Tan LK, Borgen PI, Van Zee KJ. A prospective validated model for predicting axillary node metastases based on 2000 sentinel node procedures: the role of tumour location. Eur J Surg Oncol 2002; 28: 490-500.
26. Zucali R, Mariani L, Marubini E, Kenda R, Lozza L, Rilke F et al. Early breast cancer: evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol 1998; 16: 1363-1366.
27. Kroman N, Wohlfahrt J, Mouridsen HT, Melbye M. Influence of tumor location on breast cancer prognosis. Int J Cancer 2003; 105: 542-545.
28. Zogakis TG, Wetherille RE, Christensen RD, Ose KJ, Friedman JD, Colbert M et al. Intraoperative subareolar injection of 99m Tc-labeled sulfur colloid results in consistent sentinel lymph node identification. Ann Surg Oncol 2005; 12: 167-172.
29. Veronesi U, Luini A, Galimberti V, Marchini S, Sacchini V, Rilke F. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990; 16: 127-133.
30. Senofsky GM, Moffat FL Jr, Davis K, Masri MM, Clark KC, Robinson DS et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 1991; 126: 1336-1341.
31. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-553.